Ixekizumab

Taltz

達癬治注射劑

80mg/1ml/autoinjector

05. BIOLOGIC AND IMMUNOLOGIC AGENTS; ;

05.05. IMMUNOLOGIC AGENTS;;

Anti-interleukin 17A Monoclonal Antibody
Antipsoriatic Agent

斑塊性乾癬、乾癬性關節炎、僵直性脊椎炎、中軸性脊椎關節炎

Unknown

Unsafe

SC
Plaque psoriasis
Adult: 160mg once, followed by 80 mg at weeks 2, 4, 6, 8, 10, and 12, and then 80 mg every 4 weeks.
Children <25 kg: 40 mg once, followed by 20 mg every 4 weeks.
Children 25 to 50 kg: 80 mg once, followed by 40 mg every 4 weeks.
Children >50 kg: 160 mg once, followed by 80 mg every 4 weeks.
Psoriatic arthritis
160 mg once, followed by 80 mg every 4 weeks.
Ankylosing spondylitis
160 mg once, followed by 80 mg every 4 weeks.
Non radiographic axial spondyloarthritis
80 mg every 4 weeks.

Injection-site reaction(erythema, pain) , oral candidiasis, urticaria

1.治療前應評估病人是否感染結核病
2.藥品應冷藏於2-8℃
3.藥品須避光保存直至使用時。
4.若將藥品放置於室溫30℃以下，最多可保存5天，如未使用須銷毀。

建立者

103617

建立時間

2024-10-23 08:05:53

維護者

103617

維護時間

2024-10-23 08:12:39